Histrelin
Links shared publicly online about this topic
Once-Yearly Histrelin Subdermal Implant Provides Long-Term Efficacy In Prostate Cancer Patients
medicalnewstoday.com — “BARCELONA - The luteinizing hormone- releasing hormone (LHRH) agonist histrelin acetate (VantasR), a subcutaneous implant replaced once yearly, maintains testosterone suppression over four years” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2010 at 9:10 pm By:
Once-Yearly Histrelin Subdermal Implant Provides Long-Term Efficacy In Prostate Cancer Patients http://mnt.to/3Bwy #healthnews
A review of the use of histrelin acetate in the tr... [BJU Int. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 21, 2009 at 8:09 am By:
A review of the use of histrelin acetate in the treatment of prostate cancer. - http://bit.ly/19h4nZ
Urology Article | Prostatic Neoplasms
mdlinx.com — “Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer” View full resource at mdlinx.com
Most Recently Shared on September 7, 2011 at 8:15 pm By:
Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients w... http://t.co/Zobk3Z5 #urology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
-
prostate_cancer
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

